Description
Evidence-based guidance for safe, effective ADHD prescribing in General Practice
Aligned with the Australian Evidence-Based Clinical Practice Guideline for ADHD (2022), this prescribing guide provides GPs with practical, step-by-step protocols for continuing care of patients with established ADHD diagnoses and stable medication plans.
The guide outlines best-practice approaches to continuing care for patients with an established ADHD diagnosis and a stable medication plan — with step-by-step direction on when to review, when to refer, and how to collaborate effectively with specialists.
RACGP-endorsed clinical resource
This guide has been endorsed by the Royal Australian College of General Practitioners as an approved clinical resource.
Supporting healthcare reform and better patient outcomes
Developed to support NSW’s Tier 1 General Practice reforms, this guide addresses the growing role of primary care in ADHD management. As more GPs take on ADHD care, effective collaboration across primary care, psychiatry, paediatrics, and allied health becomes essential to delivering consistent, high-quality care for all patients—including underserved populations such as girls and women, and First Nations communities.




